Compare Abeona Therapeutics Inc (ABEO) vs VanEck Video Gaming and eSports ETF (ESPO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs VanEck Video Gaming and eSports ETF — how do they compare? Abeona Therapeutics Inc trades at $6.74 (market cap $373.32M), while VanEck Video Gaming and eSports ETF trades at $92.17. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, VanEck Video Gaming and eSports ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | ESPO | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Sector/Thematic |
52-Week High | $7.23 | $122.30 |
52-Week Low | $4.17 | $85.25 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
ESPO (VanEck Video Gaming and eSports ETF) trades at $92.89, up 1.04% with bullish technical signals from moving averages. The ETF benefits from AI-driven gaming industry growth potential, with institutional interest shown by Assetmark's 35.9% position increase. Technical indicators show strong trend momentum despite overbought short-term RSI conditions.
The gaming ETF presents exposure to digital entertainment's structural growth, with AI potentially unlocking $22B in industry profits. Key risks include thematic ETF volatility and gaming sector competition. Support at $91-$92 levels provides near-term technical foundation for the current bullish trend.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About VanEck Video Gaming and eSports ETF
ESPO is a thematic ETF that invests in the global video gaming and eSports industry. It provides exposure to companies involved in game development, hardware, and streaming, including major firms like Tencent, Nintendo, and Electronic Arts.
Read more on ESPO →
